23 C
New York
Sunday, June 14, 2026

Tag: overdose

newssourceFORcompanyinformationcontent1marketreleases

NEDHSA Celebrates Ribbon-Cutting of R.I.S.E. Treatment Center to Address Maternal Mortality and Substance Use Disorders

MONROE, La., June 11, 2026 /PRNewswire/ -- Northeast Delta Human Services Authority (NEDHSA) officially dedicated the Reaching Independence through Support & Education (R.I.S.E.) Treatment...

Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose

Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources 
Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources

The Ad Council and Sugar23 Launch Ad Council Entertainment

New Partnership to Develop Premium Film and TV Entertainment for Social Impact and Culture Change NEW YORK, Aug. 14, 2025 /PRNewswire/ -- The Ad Council,...

Rogue Recovery Announces Grand Opening in Grants Pass, Offering Vital Support for Rural Communities Struggling To Address Addiction Rates

GRANTS PASS, Ore., Aug. 13, 2025 /PRNewswire/ -- Rogue Recovery, a recovery community organization (RCO) dedicated to providing comprehensive peer-based support, resources, and mentoring...

The SBB Research Group Foundation Sponsors Live4Lali

CHICAGO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Live4Lali collaborated in a volunteer initiative alongside the SBB Research Group Foundation, which partners with local nonprofits through its Champion A Charity Program. 

NSC Applauds Senate Appropriations Committee Passage of Bill Keeping OSHA, NIOSH Funding Steady

WASHINGTON, Aug. 1, 2025 /PRNewswire/ -- Today, the National Safety Council issued the following statement in response to the U.S. Senate Appropriations Committee's passage of...

Indivior Real World Evidence Study Finds Medications for Opioid Use Disorder, Particularly Extended-Release Buprenorphine, Reduced Odds of Emergency Department Visits for Patients with Opioid...

Extended-release buprenorphine (BUP-XR) had lower rates of hospitalizations, emergency department (ED) visits, and outpatient physician office visits compared to those receiving daily oral buprenorphine or no medications for...

NOTICE TO THE MEDIA – Government of Canada to make an announcement on helping to address the substance use and overdose crisis in the...

FREDERICTON, NB, July 18, 2025 /CNW/ - The Honourable Marjorie Michel, Minister of Health, will make an important announcement on helping to address the...

Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates

TEMPE, Ariz., July 15, 2025 /PRNewswire/ -- Cummings Graduate Institute for Behavioral Health Studies (CGI) proudly celebrated the graduation of seven new Doctors of...

Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue

ORLANDO, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy Inc. (OTC: BLEG), a diversified holdings company, today announced significant changes in its leadership structure and a strategic merger initiative aimed at positioning the company for growth in the burgeoning addiction therapeutics sector.

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for Strategic Preparedness and Response (ASPR), part of the U. S. Department of Health and Human Services (HHS), for smallpox preparedness. ASPR exercised an option from its existing 10-year contract (75A50119C00037) for additional doses of VIGIV, a treatment for complications due to smallpox vaccination.

Novartis receives approval for first malaria medicine for newborn babies and young infants

Basel, July 8, 2025 – Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.

US Senate Candidate Mike Faris Exposes Billionaire Nate Morris’s Blindspot, Kentucky’s Healthcare Crisis

LEXINGTON, Ky., July 7, 2025 /PRNewswire/ -- Kentucky's US Senate candidate Mike Faris's opponents, Daniel Cameron, Andy Barr, and billionaire Nate Morris, don't list healthcare...

Speranza Therapeutics and Sunshine Labs Announce Strategic Global Partnership to Expand Access to Life-Saving Harm Reduction Solutions

BOCA RATON, Fla. and TORONTO, June 25, 2025 /PRNewswire/ -- Speranza Therapeutics is proud to announce a strategic partnership with Sunshine Labs, a global leader...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOverdose

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers